Newly Diagnosed Glioblastoma

NCT04959500 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Anlotinib Hydrochloride
DRUG: Placebo
RADIATION: Radiation Therapy
DRUG: Temozolomide

Sponsor

Sun Yat-sen University